To evaluate the translational relevance of our platform, we validated the cell surface expression of HER2, IL13Rα2, and EphA2 in a patient-derived GBM cell line (Ge518) (Figure 7A), which we then employed in an orthotopic resection model of GBM (Figures 7B–7G). This evidence concerns the gene ERBB2 and glioblastoma.